DavidRobertBoulwareMDMPH
Infectious Disease • Minneapolis, MNHIV/AIDS Medicine, International Health, Travel & Tropical
Distinguished Associate Professor of Medicine, University of Minnesota Medical School, Minneapolis
Dr. Boulware is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
420 Delaware St Se
Mmc 250
Minneapolis, MN 55455Phone+1 612-625-7634
Summary
- Dr. David Boulware is an infectious disease specialist in Minneapolis, MN and is affiliated with University of Minnesota Medical Center, Fairview. He received his medical degree from Indiana University School of Medicine and has been in practice 17 years. He specializes in hiv/aids medicine and international health, travel & tropical and is experienced in cryptococcal meningitis, parasitic infections, vaccines, aids-related opportunistic infections, and diagnostic services.
Education & Training
University of MinnesotaFellowship, Infectious Disease, 2004 - 2007- University of MinnesotaResidency, Internal Medicine/Pediatrics, 2000 - 2004
Indiana University School of MedicineClass of 2000
Certifications & Licensure
MN State Medical License 2002 - 2025
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Prevention of Jellyfish Stings Start of enrollment: 2004 Apr 01
- Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory Effect of Chloroquine Start of enrollment: 2006 Mar 01
- Passive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes Start of enrollment: 2008 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Diagnostic Accuracy of the Updated FujiLAM II Assay to Detect Tuberculosis in Outpatients With Advanced HIV Disease.Tessa Adzemovic, Elizabeth Nalintya, Ann Fieberg, Emmanuel Mande, Katende George
Clinical Infectious Diseases. 2025-03-25 - Sex-specific associations between cerebrospinal fluid inflammatory biomarkers and cognition in antiretroviral-naïve people with HIV in rural Uganda.Julia Denniss, Rebecca T Veenhuis, Yanxun Xu, Lang Lang, Deanna Saylor
Brain, Behavior, and Immunity. 2025-03-01 - Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Pr...Jane Gakuru, Enock Kagimu, Biyue Dai, Samuel Okurut, Laura Nsangi
Clinical Infectious Diseases. 2025-02-24
Journal Articles
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19David Boulware, MD, The New England Journal of Medicine
- HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 CountsDavid Boulware, MD, The Journal of Infectious Diseases
- Oxford University Press Has Registered This DOI Pre-PublicationChristopher C Moore, David R Boulware, Eric R Houpt, Oxford University Press
- Join now to see all
Authored Content
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19June 2020
Press Mentions
What Did We Learn from the Earliest COVID Trials?March 10th, 2025- Three Effective Treatments for COVID-19 Not in Treatment Guidelines — at Least Not YetMarch 27th, 2023
- Steroid Drug Reduces Death Rate in Severe Pneumonia, Study ShowsMarch 21st, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
